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Abstract 
Mast cell hyperplasia is observed in various inflammatory skin diseases. Although the 
pathogenesis of these conditions remains largely uninvestigated, it is speculated that 
lesional mediators provide favorable microenvironment for mast cell growth. We have 
investigated the effect of an inflammatory cytokine, IL-1α, on mast cell growth in a mast 
cell/fibroblast co-culture system. When mouse bone marrow-derived cultured mast cells 
(BMMC) were cultured on a NIH/3T3 fibroblast monolayer, IL-1α stimulated mast cell 
proliferation. However, IL-1α did not stimulate 
3
H-thymidine incorporation in BMMC in 
the absence of fibroblasts. Separation of BMMC from fibroblasts by a permeable 
micropore membrane reduced the effect of IL-1α. When BMMC were prepared from 
W/Wv-mice, which lack functional c-kit, or when NIH/3T3 fibroblasts were substituted 
with Sl/Sl
d
-derived fibroblasts, which lack membrane-bound stem cell factor (SCF), a 
lower, but significant, effect of IL-1α was observed. Flow cytometric analysis revealed 
no enhancement of SCF expression on fibroblasts by IL-1α. Neutralizing antibodies 
against IL-3, IL-4, IL-10, and nerve growth factor (NGF) showed no inhibition. On the 
other hand, indomethacin inhibited the effect of IL-1α, and prostaglandin E2 induced 
mast cell growth in the co-culture. These results indicate that IL-1α stimulates mast cell 
growth by a fibroblast-dependent mechanism, where SCF/c-kit interaction may 
participate in a major way. The mast cell growth activity induced by this cytokine is, at 
least in part, attributed to prostaglandins. Inflammatory cytokines may thus contribute to 
mast cell hyperplasia in skin diseases.  
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Introduction 
Mast cells release inflammatory chemical mediators, such as histamine, leukotrienes, and 
prostaglandins, on IgE-mediated stimulation with specific allergen. Mast cells thus play a 
pivotal role in immediate hypersensitivity reactions. In addition, recent studies have 
revealed that mast cells produce a wide plethora of cytokines, suggesting their active 
participation in the late phase reaction and chronic stage of inflammation [1, 2]. 
     Mast cells increase in a variety of inflammatory skin diseases, such as atopic 
dermatitis, contact dermatitis, and in actinically damaged skin [1]. Repeated topical 
application of antigens [3, 4], phorbol-myristate-acetate [5], or ultraviolet light irradiation 
[6] is documented to induce increase in mast cells along with skin inflammation. But the 
pathogenesis of mast cell accumulation in these conditions remains largely uninvestigated. 
      Accumulation of mast cells could be attributed to several mechanisms, that is, ingress 
of mast cell precursors, attraction of surrounding mast cells, prolonged survival, and local 
proliferation of mast cells. Mitoses of mast cells observed in contact dermatitis [7] and 
atopic dermatitis [8] suggest that local proliferation is a possible mechanism involved. 
     Mast cells originate from hematopoietic stem cells in the bone marrow and are 
distributed to the peripheral connective tissues in premature form. Mast cells proliferate 
or complete their differentiation in the tissue where they reside, depending on the tissue 
microenvironment. The mechanism of mast cell growth has been largely investigated in 
murine system, and recent studies using human system revealed substantial differences 
between two species. In murine system, IL-3 and stem cell factor (SCF) induce mast cell 
proliferation and IL-4 enhances the effect of these cytokines. While in human system, 
SCF is the only known mast cell growth factor to date and IL-3 and IL-4 have little effect. 
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Thus, the results obtained in studies using murine mast cells could not be simply applied 
to human system. However, it is common in both species that stromal cells play an 
important role. Indeed, in mast cell/fibroblast co-culture system, mouse skin-derived 
fibroblasts maintain and induce differentiation of mast cells of mice [9], as well as mast 
cells of human [10, 11]. 
In normal skin, mast cells are usually observed in the upper dermis, around blood 
vessels and nerves, and mast cells observed in inflammatory skin diseases are frequent in 
superficial dermis [5, 12, 13]. These suggest that fibroblasts, major cellular component of 
the dermis, play an important role also in vivo, and that this mast cell-fibroblast 
interaction is affected by local inflammatory mediators. 
     In this investigation, we studied the effect of an inflammatory cytokine, IL-1α, on 
mast cell growth in the murine mast cell/fibroblast co-culture system. In skin 
inflammation, IL-1α is produced by keratinocytes, as well as various infiltrating 
inflammatory cells, such as macrophages and lymphocytes. Therefore, our results serve 
to elucidate the pathomechanism of mast cell hyperplasia in inflammatory skin diseases.  
 
Materials and methods 
 
Cytokines and antibodies 
 
Recombinant murine IL-1α, IL-3, IL-4, IL-10, and SCF were purchased from R&D 
systems (Minneapolis, MN). Mouse submaxillary gland-derived 2.5S nerve growth factor 
(NGF) was purchased from Harbor Bio-Products (Norwood, MA) and Toyobo (Osaka, 
Japan). Antibodies; goat anti-mouse IL-1α, IL-3, IL-4, were purchased from R&D 
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systems, anti-mouse IL-10 antibody was purchased from Endogen (Cambridge, MA), 
goat anti-mouse SCF was purchased from Santa Cruz Biotechnology (Santa Cruz, CA), 
and sheep anti-NGF was purchased from Chemicon International (Temecula, CA). 
Indomethacin and prostaglandin E2 (PGE2) were purchased from Sigma (St. Louis, MO). 
 
Cells 
 
Bone marrow-derived cultured mast cells (BMMC) were obtained by culturing bone 
marrow cells of 6-week-old male mice, WBB6F1-W/W
v
 (W/W
v
) and their normal 
littermates WBB6F1-+/+ (+/+) (Shizuoka Laboratory Animal Center, Shizuoka, Japan), 
as previously described [14, 15]. Briefly, bone marrow cells suspended at a density of 
1x106/ml in αMEM medium (Dainippon Pharmaceutical, Osaka, Japan) supplemented 
with 10% heat-inactivated (56°C, 30 min) fetal calf serum, 100 IU/ml penicillin G (Meiji 
Pharmaceutical Co., Tokyo, Japan) and 100 µg/ml streptomycin (Meiji) (complete 
αMEM) with 5 ng/ml of IL-3 and 2 ng/ml of IL-4 were cultured at 37°C in a humidified 
atmosphere of 5% CO2 in air. Non-adherent cells were collected by centrifugation and re-
suspended in fresh medium every 7 d. After 4 weeks, more than 95% of the non-adherent 
cells stained positively with alcian blue.  
     NIH/3T3 fibroblasts (ATCC No. CRL1658) were maintained in complete αMEM at 
37°C in humidified atmosphere of 5% CO2 in air. Mouse skin fibroblasts were prepared 
from the dermis of +/+-mice. Sl/Sl
d
-3T3 fibroblasts were kindly provided by Dr. Y. 
Kitamura (Department of Pathology, Osaka University Medical School, Osaka, Japan). 
 
Co-culture 
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Co-culture of BMMC with NIH/3T3 fibroblasts was performed as described previously 
[15] with slight modification. Briefly, 2x104 NIH/3T3 fibroblasts suspended in 0.5 ml of 
complete αMEM were seeded in each well of four-well multidishes (Nunc, Roskilde, 
Denmark). Upon reaching confluence, the medium was aspirated and 0.5 ml of medium 
containing various concentrations of cytokines and 2-3x10
4
 BMMC were added. The 
cells were cultured at 37°C in a humidified atmosphere of 5% CO2. The cultures were fed 
with fresh media every other day. 
     In a set of experiments, confluent monolayers of fibroblasts were incubated with 50 
µg/ml mitomycin C (Kyowa Hakko Kogyo Co., Tokyo, Japan) at 37°C for 30 min. After 
thorough washing, pretreated monolayers were used for the co-culture. 
     In the pre-incubation experiment, confluent monolayers of fibroblasts were incubated 
with IL-1α for 6 h before use in the co-culture. In this experiment, BMMC and 
fibroblasts were co-cultured for 3 d without medium change. 
 
Mast cell counting in co-culture 
 
Adherent cells in the co-culture wells were treated with PBS containing 0.1% (w/v) 
trypsin (Difco Laboratories, Detroit, MI) and 0.27 mM EDTA for 10 minutes at 37°C, 
followed by the addition of one tenth volume of fetal calf serum. The dispersed cells were 
washed twice with PBS and suspended in 1 ml of PBS. Total number of the cells in the 
suspension was determined using a hemocytometer. Aliquots of cell suspensions were 
cytocentrifuged and resulting cell preparations were stained with alcian blue after fixation 
with Carnoy's solution. The number of mast cells, regarded as alcian blue positive cells, 
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in co-cultures were calculated using the following formula: number of mast cells/well = 
A x C/B, where A is total number of the cells in a well counted with hemocytometer, B 
total number of cells counted on a cytocentrifuge specimen, and C number of alcian blue 
positive cells in the same specimen.  
 
Determination of histamine content in co-culture 
 
Cultured cells in each co-culture well were denatured by adding HClO4 at a final 
concentration of 0.25 M, and insoluble proteins were precipitated by centrifugation at 
10000 g for 10 min. Histamine concentration in the supernatants was assayed with 
automated fluorometric-HPLC system (Tosoh Corporation, Tokyo, Japan) as previously 
described [16]. 
    
Separation of mast cells from fibroblasts by using micropore membrane 
 
Mast cells were cultured in the tissue culture inserts where they share the same medium 
with NIH/3T3 fibroblasts, but separated by a 0.2 µm pore membrane (Anopore 
membrane
TM
, Nunc). Culture medium was added into both the inner and outer sides of 
the inserts, and BMMC were seeded into the inner side at the start of the co-culture. 
Culture medium of outer side was replaced on day 2, 4, and 6, then BMMC in the inserts 
were harvested on day 7. In this experiment, cell number was determined using a 
hemocytometer. 
 
3
H-thymidine incorporation 
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BMMC were plated in wells (1x10
4
 cells/well) of 96-well in multiwell plates (Becton 
Dickinson Labware, Franklin Lakes, NJ) with cytokines or medium alone and incubated 
for 36 h. Then BMMC were pulsed with 0.5 µCi 3H-thymidine (specific activity, 5 
Ci/mmol, Dupont-New England Nuclear, Boston, MA) and further incubated for 12 h. 
The cells were harvested on glass filters and incorporated radioactivity in the cells was 
assayed in a liquid scintillation counter (LSC5100, Aloka, Tokyo, Japan). 
 
Flow cytometric analysis of SCF expression 
 
Fibroblasts were detached from culture flasks by incubation with PBS containing 5 mM 
EDTA. Harvested cells were washed and suspended in PBS containing 1 % BSA and 
0.1 % sodium azide. After incubation with 10 % normal donkey serum (Chemicon), cells 
were aliquoted and incubated with goat anti-mouse SCF antibody or normal goat IgG. 
Cells were stained with FITC-conjugated donkey anti-goat IgG antibody and analyzed in 
a Becton Dickinson FACScaliber flow cytometer. 
 
Statistics 
 
For statistical analyses, t-test and Bonferroni test were used to compare two groups and 
more than three groups, respectively. 
 
Results 
 
Enhancement of mast cell growth by IL-1α in the mast cell/fibroblast co-culture system 
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When BMMC prepared from +/+-mice were seeded on a confluent monolayer of 
NIH/3T3 fibroblasts, 44.7 ± 9.3 % (mean ± SD, n=8) of the BMMC adhered to the 
monolayer within 48 h in the control medium. IL-1α did not significantly alter the 
proportion of adherent BMMC: 30.2 ± 1. 8 % in the presence of 10 ng/ml of IL-1α. But 
this cytokine induced proliferation of BMMC after the co-culture of 7 d in a dose-
dependent manner (Fig. 1A) and total histamine content paralleled mast cell number in 
the same experiments (Fig. 1B). When mast cells were cultured in the presence of 10 
ng/ml of IL-1α, mast cell number increased in a time-dependent manner during the first 
10 d in the co-culture (Fig. 1C) and total histamine content paralleled also in these 
experiments (data not shown). These indicated that total histamine content could serve as 
an indicator of mast cell number in the co-culture of 7 d. The mast cell growth enhancing 
effect of IL-1α was reduced by anti-IL-1α antibody (data not shown). 
  
Direct effect of IL-1α on mast cell proliferation 
 
As IL-1α enhanced mast cell growth in the mast cell/fibroblast co-culture system, we 
have next examined whether this cytokine stimulates mast cell proliferation directly. 
When mast cells were cultured without fibroblasts for 48 h, 
3
H-thymidine incorporation 
in the last 12 h was 81 ± 10 cpm, 54 ± 7 cpm, and 7111 ± 598 cpm (mean ± SEM, n=3), 
in the control medium, 10 ng/ml of IL-1α, and 50 ng/ml of SCF, respectively. The effect 
of the cytokine was also evaluated by direct cell counting. When 1x10
5
 cells/well
 
BMMC 
were cultured without fibroblast, mast cell number rapidly decreased and viable cells 
were less than 5x10
3
 cells/well after 5 d even in the presence of IL-1α, whereas SCF 
 10 
induced substantial proliferation of mast cells, 1.6x10
5
 ± 1.4x10
4
 cells/well (mean ± SEM, 
n=3) were observed after 5 d, in the same experiments. IL-1α does not directly stimulate 
mast cell proliferation. 
 
Pre-incubation of fibroblasts with IL-1α 
 
As it was suggested that IL-1α induces mast cell growth by a fibroblast-dependent 
mechanism, we then studied the effect of pretreatment of fibroblasts with IL-1α. Pre-
treatment of fibroblasts with 10 ng/ml of IL-1α for 6 h induced a significantly larger mast 
cell number after 3 d: 27281 ± 669 and 21587 ±1110 cells/well (mean ± SEM, n=3, 
p<0.01), in the co-culture with IL-1α-treated fibroblasts and with control fibroblasts, 
respectively. This indicates that IL-1α stimulates fibroblasts for the production of mast 
cell growth factor, and the coexistence of IL-1α was not necessary for the activity of this 
fibroblast-derived mast cell growth factor. On the other hand, conditioned medium of 
fibroblasts stimulated with IL-1α for 24 h showed no mast cell growth activity in 3H-
thymidine incorporation experiments (data not shown). 
To further characterize the interaction of mast cells and fibroblasts in the co-culture 
system, we separated mast cells from fibroblasts by using micropore membrane, which 
prevented cellular contact but allowed diffusion of soluble mediators. Mast cell growth 
was observed even when mast cells were separated from fibroblasts, but the effect was 
significantly lower than that observed without membrane (Fig. 2). For efficient mast cell 
proliferation in this system, mast cells should locate close to or in contact with fibroblasts. 
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Effect of mitomycin C treatment of fibroblasts 
 
It is possible that mast cell proliferation is merely the result of fibroblast proliferation, 
because fibroblasts can maintain mast cells in co-culture [9] and IL-1α stimulates 
fibroblast proliferation [17]. In dose-response and time course experiments, those shown 
in Fig. 1, we found that IL-1α increased the mast cell number per fibroblast. This 
suggests that mast cell growth is not only due to fibroblast proliferation. To confirm this, 
we treated the fibroblast monolayer with the cytostatic agent, mitomycin C, before their 
use in the co-culture (Table 1). By the mitomycin C treatment, fibroblast proliferation 
was blocked, and there was no significant difference in fibroblast numbers after cytokine 
stimulation. However, mitomycine C treatment did not significantly alter mast cell 
number after the co-culture, indicating that mast cell growth in this system is not 
necessarily related to fibroblast proliferation. 
   
Involvement of SCF in IL-1α-induced mast cell growth in the co-culture 
 
Fibroblasts constitutively produce one of the potent mast cell growth factors, SCF, 
predominantly in membrane-bound form [18]. SCF binds its receptor, c-kit product, on 
mast cells to stimulate proliferation. Littermates of +/+-mice, W/W
v
-mice have mutations 
in the tyrosine kinase domain of c-kit, and BMMC derived from W/W
v
-mice do not 
proliferate in response to SCF. To examine whether the SCF/c-kit pathway mediated the 
IL-1α-stimulated mast cell growth, we have used W/W
v
-derived BMMC in the co-culture 
(Fig. 3). Although mast cell number and histamine content after 7 d was lower than that 
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observed with +/+-BMMC, IL-1α caused significant differences in mast cell number, in 
parallel with total histamine content, in W/W
v
-BMMC/fibroblast co-culture. 
The effect of IL-1α was also evaluated in the combination of +/+-derived BMMC and 
the fibroblasts derived from Sl/Sld mice, which lack membrane bound form of SCF (Fig. 
4). Similar to the experiments with W/W
v
-derived BMMC, IL-1α caused a significant 
difference in histamine content in this cell combination, although, the absolute content 
was much lower than that with NIH/3T3 fibroblasts. 
As a partial involvement of SCF was indicated, we then assessed whether IL-1α could 
enhance SCF expression on fibroblasts by indirect immunofluorescence staining and flow 
cytometry. Although constitutive expression of SCF on fibroblasts was observed, the 
expression was not altered by the incubation of fibroblasts with 10 ng/ml of IL-1α for 24 
h (data not shown). 
We have also examined whether another mast cell growth factor, IL-3, or co-factors 
for mast cell growth, IL-4 and IL-10 [19, 20], are involved in the cytokine-stimulated 
mast cell growth. As shown in Table 2, neutralizing antibodies against these factors did 
not inhibit mast cell growth induced by IL-1α in the co-culture. NGF was reported to 
induce proliferation of BMMC and development of connective tissue-type mast cells in 
the co-culture in the presence of IL-3 [21]. However, NGF obtained from several 
companies failed to induce mast cell growth in the concentration range from 1 pg/ml to 
100 ng/ml in our system, in which IL-3 was not supplemented (data not shown). 
 
Involvement of PG in the cytokine-induced mast cell growth in the co-culture 
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We have used a cyclooxygenase inhibitor, indomethacin, to examine whether this 
enzyme and prostanoids are involved in the cytokine-stimulated mast cell growth in the 
co-culture (Fig. 5). Indomethacin significantly reduced the effect of IL-1α on both +/+- 
and W/Wv-BMMC. These results indicate that cyclooxygenases are involved in the 
cytokine-induced mast cell growth in the co-culture, and prostanoids comprise the mast 
cell growth activity produced by fibroblasts. Indeed, the addition of PGE2 in the co-
culture induced significant increase in mast cell number and total cellular histamine (Fig. 
6). 
 
Effect of IL-1α on growth of mast cells cultured on skin-derived fibroblasts 
 
We examined whether IL-1α induces proliferation of BMMC cultured on skin-derived 
fibroblasts as well as NIH/3T3 fibroblasts. Fibroblasts were prepared from the skin of 
+/+-mice, the strain from which BMMC were prepared, and used in the co-culture. As 
shown in Fig. 7, IL-1α induced increase in total histamine content, which indicates 
increase in mast cell number in 7 d culture, in the same concentration range. The 
cytokine-induced mast cell growth mechanism appears also effective in the co-culture 
with dermal fibroblasts. 
 
Discussion 
In this study we demonstrated that an inflammatory cytokine, IL-1α induced mast cell 
growth in BMMC/fibroblast co-culture system (Fig. 1). The effect was observed not only 
in the co-culture with NIH/3T3 fibroblasts, which is established from mouse embryo, but 
also in the co-culture with skin-derived fibroblasts prepared from the same strain from 
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which BMMC were obtained (Fig. 7). As IL-1α is produced by keratinocytes and 
infiltrating cells in inflammatory lesions, this cytokine-stimulated fibroblast-dependent 
mast cell growth mechanism may play a role in mast cell hyperplasia observed in chronic 
skin inflammation.  
     IL-1α by itself does not stimulate mast cell proliferation directly, but stimulates 
fibroblasts to produce mast cell growth activity. The considerable reduction in mast cell 
growth by the separation of BMMC from fibroblasts by micropore membrane (Fig. 2) 
and no effect of IL-1α-stimulated fibroblast conditioned medium suggest the importance 
of membrane-associated factor(s) in the mast cell growth. Subsequent experiments using 
defective cell lines indicated the involvement of SCF, a well characterized mast cell 
growth factor, which is constitutively produced by fibroblasts predominantly in the 
membrane-bound form [18]. Employment of W/Wv-derived BMMC (Fig. 3) or Sl/Sld-
derived fibroblasts (Fig. 4) in the co-culture resulted in lower mast cell number and/or 
histamine content after 7 d in the presence of IL-1α, suggesting the major role of SCF/c-
kit pathway in the mast cell growth. 
     As mast cell growth was observed in the co-culture with mitomycin C-treated 
fibroblasts (Table 1), mast cell growth is not simply induced by fibroblast proliferation 
and the consequent increase in SCF. However, flow cytometric analysis revealed that the 
treatment with IL-1α induced no enhancement of SCF expression on the fibroblasts (data 
not shown). Although conflicting results were reported about SCF expression on 
cytokine-stimulated human umbilical vein endothelial cells [22-24], our observation 
agrees with that of Heinrich et al. [25], who described that SCF expression on human 
fibroblasts was not altered by IL-1α. Moreover, both cytokines induced a significant 
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difference in mast cell number and/or histamine content in the co-culture with cells that 
have a defect in SCF/c-kit pathway (Fig. 3, 4). These results indicate the presence of an 
additional pathway modulated by IL-1α. 
     Indomethacin inhibited the cytokine-induced mast cell growth in the co-culture (Fig. 
5). This suggests that cyclooxygenase, the rate-limiting enzyme of prostanoid synthesis, 
is involved in the mast cell growth mechanism. Indeed a product of cyclooxygenase 
pathway, PGE2, induced the growth of mast cells in the co-culture (Fig. 6), indicating a 
probable role of prostanoids. IL-1α is known to stimulate PG synthesis of fibroblast by 
inducing the expression of cyclooxygenase-2 [26]. As indomethacin also inhibited the 
growth of W/Wv-derived BMMC in the co-culture, it is likely that cyclooxygenase 
pathway constitutes the additional pathway modulated by IL-1α. On the other hand, 
neutralization experiments using antibodies against IL-3, IL-4, IL-10, and NGF, indicated 
that these factors and co-factors for mast cell growth are unlikely to be involved. 
     It is consequently speculated that mast cell growth activity induced by IL-1α in 
fibroblasts is, at least in part, attributed to prostanoids, and that the signal conducted via 
SCF/c-kit pathway is important for this cytokine-induced mast cell growth activity, 
and/or SCF/c-kit interaction serves as adhesion molecules that keep mast cells in contact 
with or in close range of fibroblasts. Considering that the extracellular domain of c-kit 
expressed on W/Wv-derived BMMC is intact and can serve as adhesion molecule [27], 
SCF/c-kit-mediated signal seems to be essential for efficient fibroblast-dependent mast 
cell growth. 
     In time course experiments (Fig 1C), the effect of IL-1α was observed only in the 
earlier time period. Although it remains to be clarified, this limitation could be attributed 
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to the culture condition, in which contact-inhibited fibroblast monolayers were 
continuously stimulated with a mitogenic cytokine, which might affect the property of 
fibroblasts. Indeed, at the end of 14-d co-culture stimulated with higher concentration of 
IL-1α, fibroblasts showed a tendency to easily detach from culture dishes. 
     Hu et al. [28] reported that PGE is essential for IL-3-dependent mouse mast cell 
induction from spleen cells. The authors concluded that PGE acts on mast cell precursors, 
but not on committed immature mast cells. In human system, PGE2 enhances mast cell 
differentiation from cord blood mononuclear cells by inhibiting the production of 
macrophage-derived GM-CSF, which induce the differentiation into granulocyte-
macrophage lineage [29]. Our results indicate that PGE2 also enhance the growth of 
differentiated mast cells in the co-culture system. It has been reported that keratinocyte-
derived IL-1α induces increased PGE2 production from dermal fibroblasts in human 
keratinocyte/fibroblast co-culture [30]. It is therefore possible that IL-1α-induced 
prostaglandin synthesis is involved in the mast cell growth mechanism in human skin. 
     In conclusion, our results indicate that inflammatory cytokines induce mast cell 
growth by a fibroblast-dependent mechanism. The data in a murine system might not 
exactly apply to the human system, however, our findings may lead to the elucidation of 
the pathogenesis of mast cell hyperplasia observed in inflammatory, not necessarily 
allergic, skin diseases. 
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Table 1.  Mitomycin C treatment of fibroblasts. Confluent monolayers of fibroblasts were 
incubated with 50 µg/ml of mitomycin C or medium at 37°C for 30 min. After thorough washing, 
BMMC were seeded on the monolayer and co-cultured in the presence of 10 ng/ml of IL-1α or 
control medium. Fibroblast and mast cell number was determined on day 7. Results were 
expressed as mean ± SEM of four experiments performed in quadruplicates. 
 
Without mitomycin C treatment  With mitomycin C treatment 
 
Fibroblast number Mast cell number  Fibroblast number Mast cell number 
Medium  233439 ± 18078  11874 ± 2342   43279 ± 2339
a
  9533 ± 2597 
IL-1α  251270 ± 17520  25605 ± 2188
b
   53035 ± 7552
a
  25715 ± 1197
b
 
 
a
p<0.01 versus cell numbers without mitomycin C treatment. 
b
p<0.01 versus medium control in each treatment group.
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Table 2.  Neutralization experiments with antibodies against IL-3, IL-4, IL-10, and NGF. BMMC 
were co-cultured with NIH/3T3 fibroblasts in the presence of 10 ng/ml of IL-1α, IL-4, IL-10, 
NGF, or 5 ng/ml of IL-3 for 6 d. Each antibody was added at a final concentration of 10 µg/ml. 
Growth of BMMC was determined by total cellular histamine (ng/well) and growth index was 
calculated as follows: (growth index) = (histamine content in each co-culture) / (histamine 
content in the control co-culture without cytokine). Data are expressed as mean ± SEM of growth 
index obtained in three experiments performed in duplicate. (ND not done) 
Growth index 
With antibody 
Cytokine 
in co-culture Without 
antibody 
anti-IL-3 anti-IL-4 anti-IL-10 anti-NGF 
IL-1α 3.84 ± 0.87 2.82 ± 0.29 3.00 ± 0.71 3.42 ± 0.73 5.23 ± 1.14 
IL-3 3.24 ± 0.33 1.05 ± 0.05
a
 ND ND ND 
IL-4 2.30 ± 0.28 ND 1.04 ± 0.07a ND ND 
IL-10 3.37 ± 0.56 ND ND 1.54 ± 0.09
a
 ND 
NGF 1.04 ± 0.06 ND ND ND 1.28 ± 0.07
a
 
 
ap<0.05 versus co-culture without antibody and stimulated with the same cytokine. 
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Figure Legends 
Fig. 1  Mast cell growth induced by IL-1α in mast cell/fibroblast co-culture system. 
BMMC prepared from WBB6F1-+/+ mice were seeded on the confluent monolayer of 
NIH/3T3 fibroblast and cultured in the presence of IL-1α or medium. A, B, Cells were 
harvested on day 7 and mast cell number (A) and total histamine content (B) was 
measured. C, Cells were cultured in the presence (closed circle) or absence (open square) 
of IL-1α (10 ng/ml), and harvested at each time point. Results are expressed as mean ± 
SEM of quadruplicates in a representative of four experiments for each study. *p<0.05 
versus medium control at each time point. 
 
Fig. 2  Separation of mast cells from fibroblasts in the co-culture by using micropore 
membrane. BMMC were co-cultured with NIH/3T3 fibroblasts with or without tissue 
culture inserts attached with 0.2 µm pore membrane which separate mast cells from 
fibroblasts. Cells were cultured for 7 d in the presence of 10 ng/ml of IL-1α or medium 
alone. *p<0.01 versus medium control in each group. 
 
Fig. 3  Co-culture of BMMC derived from WBB6F1-W/W
v
 mice on the NIH/3T3 
fibroblast monolayer. BMMC prepared from WBB6F1-W/W
v mice were co-cultured on 
NIH/3T3 fibroblasts in the presence of IL-1α (10 ng/ml), SCF (30 ng/ml), IL-3, 4 (5 
ng/ml, 2 ng/ml, respectively) or medium. Mast cell number (A) and histamine content (B) 
were measured on day 7. Data are mean ± SEM of three experiments performed in 
quadruplicate. *p<0.01 versus medium control. 
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Fig. 4  Co-culture of BMMC derived from WBB6F1-+/+ mice with Sl/Sl
d
-derived 
fibroblast monolayer. BMMC prepared from +/+-mice were co-cultured with Sl/Sld-
derived fibroblasts in the presence of IL-1α (10 ng/ml), SCF (30 ng/ml), or IL-3, 4 (5 
ng/ml, 2 ng/ml, respectively). Mast cell growth was determined by total cellular 
histamine on day 7. Data are mean ± SEM of three experiments performed in 
quadruplicate. *p<0.05, **p<0.01 versus medium control. 
 
Fig. 5  Inhibition of mast cell growth by indomethacin. BMMC derived from +/+- (A) 
and W/W
v
- (B) mice were co-cultured on NIH/3T3 fibroblasts with 10 ng/ml of IL-1α or 
control medium either in the presence (closed column) or absence (open column) of 10 
µM of indomethacin. Mast cell number (A) and total cellular histamine (B) were 
determined on day 6. Results are expressed as mean ± SEM of quadruplicates in a 
representative of three experiments. *p<0.05.  
 
Fig. 6  Mast cell growth induced by PGE2 in the co-culture with NIH/3T3 fibroblasts.  
BMMC were co-cultured with NIH/3T3 fibroblasts in the presence of a series of PGE2. 
Mast cell number (A) and total cellular histamine (B) were determined on day 6. Results 
are expressed as mean ± SEM of quadruplicates in a representative of three experiments. 
*p<0.01 versus medium control. 
 
Fig. 7  Co-culture of BMMC with skin-derived fibroblasts. BMMC obtained from 
WBB6F1-+/+ mice were co-cultured on monolayers of skin-derived fibroblasts prepared 
from mice of the same strain in the presence of IL-1α or control medium for 7 d. Mast cell 
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growth was determined by total histamine content. Result of a representative of three 
experiments performed in duplicate is shown. 
インターロイキン１α(IL-1a)は線維芽細胞依存的にマスト細胞の増殖を増強する。 
 
 マスト細胞はヒスタミンなどのケミカルメディエーターを遊離することによりアレルギ
ー反応に重要な役割を演じるのみならず、種々のサイトカインを産生することにより、病
態形成に積極的に関与するものと考えられ、アレルギー性疾患以外の種々の炎症性皮膚疾
患においても増加することが知られている。皮膚マスト細胞は通常真皮上層に存在し、真
皮の主要構成細胞である線維芽細胞がマスト細胞の増殖分化に重要な役割を果たしている
ことが in vitroでは確認されているが、炎症性疾患におけるマスト細胞増殖機構については
未だ解明されていない。本研究では、炎症性皮膚疾患におけるマスト細胞の増殖機構を解
析するモデルとして、マスト細胞と線維芽細胞の共生培養系を用い炎症性サイトカイン
IL-1aがマスト細胞の増殖に及ぼす効果を検討した。 
マスト細胞としては、WBB6F1-+/+マウス骨髄を IL-3存在下で培養して得られた骨髄由
来培養マスト細胞(BMMC)を用い、線維芽細胞としては NIH/3T3 細胞を用いた。まず
BMMC を NIH/3T3 シート上で培養する共生培養系にリコンビナントマウス IL-1a を添加
したところ、IL-1a は７日間の培養において、10 pg/ml 以上の濃度で用量依存的にマスト
細胞の増殖を増強し、また 10 ng/mlの IL-1a存在下では、時間依存的な BMMCの増加が
認められた。しかし BMMCを単独で培養した場合には、IL-1aを添加しても増殖反応はみ
られないことから IL-1a のマスト細胞に対する効果は線維芽細胞依存的であることが示さ
れた。さらに、IL-1aで６時間前刺激した NIH/3T3上で BMMCを培養した場合には IL-1a
を添加しなくても 3日後の細胞数は対照に比し有意に高値であったのに対し、NIH/3T3を
IL-1aで刺激して得られた培養上清には、マスト細胞増殖活性はみられず、また共生培養系
でマイクロポアーメンブレンによりマスト細胞と線維芽細胞の接触を妨げた場合には、
IL-1a の効果は減弱した。以上の結果より、IL-1a は直接マスト細胞には作用せず、IL-1a
により線維芽細胞からマスト細胞増殖因子が産生され、その因子によるマスト細胞増殖に
は両者の接着が重要であることが示された。 
線維芽細胞は強力なマスト細胞増殖因子である Stem cell factor (SCF)を発現することが
知られているため、この系における SCFの関与について検討した。SCFには遊離型、膜型
が存在するが、上記の結果よりこの系においては膜型因子が重要であると推察されるが、
フローサイトメトリーによる検討では、IL-1a による線維芽細胞上の SCF 発現増強は認め
られなかった。機能的検討として、SCF の受容体である c-kit に変異があり、SCF による
増殖がみられない WBB6F1-Ｗ/Ｗv マウス由来の BMMC、あるいは膜型 SCF を欠損する
Sl/Sld線維芽細胞を用いて共生培養を行った場合には、IL-1aの効果は著しく減弱し、SCF
の重要性を示すものと考えられた。しかしこの場合にも IL-1a による有意の効果がみられ
たことから、IL-1aによるマスト細胞増殖には、SCF以外の因子が関わることが示された。 
すでにマウスマスト細胞に対する増殖活性を持つことが知られている IL-3，あるいは
SCF のコファクターとしてマスト細胞増殖を促進することが知られている IL-4，IL-10 の
関与についても検討した。リコンビナントマウス IL-3，IL-4，IL-10を共生培養系に添加す
るとマスト細胞の増殖が認められたが、いずれに対する中和抗体も、IL-1aによるマスト細
胞増殖を抑制しなかった。IL-3 を添加した共生培養系においてマスト細胞増殖活性が報告
されている NGFについては、我々の系（IL-3非添加）では活性が認められず、また抗 NGF
抗体による IL-1の効果の抑制も認められなかった。従って IL-1aによるマスト細胞増殖に
は既知の因子以外が関与することが推定された。共生培養系にシクロオキシゲナーゼイン
ヒビターインドメサシンを加えると IL-1a の効果が抑制されたことから、シクロオキシゲ
ナーゼ、およびその産物であるプロスタノイドが役割を演じていることが示唆され、実際
PGE1が共生培養系において用量依存的にマスト細胞増殖を示すことが確認された。 
以上の結果から、共生培養系における IL-1aによるマスト細胞増殖には、SCF-c-kitを介
する経路が重要であり、さらに IL-1aにより線維芽細胞に誘導される因子が存在すること、
その第２の経路にプロスタノイドが関与していることが示された。 
NIH/3T3 線維芽細胞はマウス胎児由来の線維芽細胞であるが、マスト細胞用の骨髄を採
取したマウスと同系の WBB6F1-+/+マウスの皮膚より採取した線維芽細胞との共生培養の
系においても同様の効果が認められた。 
従って、炎症性サイトカイン IL-1a は皮膚におけるマスト細胞の増殖を惹起しうると考
えられ、炎症性皮膚疾患、必ずしもアレルギー性に限らず、の際に認められるマスト細胞
の増加の機構の一端を解明する結果と考えられる。 
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